State Street Corp Vigil Neuroscience, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, State Street Corp holds 69,139 shares of VIGL stock, worth $552,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,139
Previous 69,139
-0.0%
Holding current value
$552,420
Previous $116,000
6.03%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VIGL
# of Institutions
52Shares Held
29.3MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$46.6 Million3.04% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.7 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$32.1 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$15.7 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$13.9 Million0.25% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $226M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...